Download Polymorphprep™ Reference Index

Polymorphprep™ Reference Index
The numbers below relate to the Axis-Shield Abstract Number in the Polymorphprep™ Abstract File.
To access this abstract file click on the double blue arrow ÄÄ
Alveolar macrophages
Rodent
Ethanol effects
Lipopolysaccharide effects
093, 109, 188
094
Erythrocytes
Human
Acute lymphoblastic leukaemia
Cytokines
Immune reaction
Phosphatidylethanol
Plasmodium studies
307
092, 187, 252
392
227
319, 414, 517
Sheep
Phagocytosis
202
Heterophils
Avian blood
Activation
E. coli infection
140
574
Leukocytes (total)
Human blood
Acute lymphoblastic leukaemia
Bacterial infection, detection of
Liver cirrhosis
Metalloproteinases
Tyrosine phosphatase inhibitor
Virus detection/infection
307
340
177, 494
177
514
054, 058, 073, 119, 167, 178
Monkey blood
DNA transmission
212
Rodent blood
DNA damage
589
Mononuclear cells
Human blood
Adenylosuccinate lyase
CDCP1 expression
Chemoattractants
Cytokines
Cytotoxicity
Defensins
DNA
Oxidative damage
Effector cell populations
Fanconi anaemia
Fibronectin
Gene expression
Heparin-binding protein
276
510
269
252, 269, 344, 393
162, 317
269
149, 201, 247, 281
532
162
526
218, 424
357, 568
430
Hepatitis
194
Lipopolysaccharide
567
Lipoprotein oxidation
175
Lymphocyte phenotypes
158
Metalloproteinases
194, 393
Monocytes
Bacterial responses
172
Cytokines
602
FcγR functions
293, 381
Gene expression
568
IgG N-glycan hydrolysis
606
Immune reactions
392
Melatonin
189
Melioidosis
542, 543
Lipopolysaccharide effect
283
Lysophosphatidylcholine
169
mRNA expression
468, 542, 543, 563
Protein kinases
Ca/calmodulin-dependent
234
Phosphatidylethanol
227
Reactive oxygen species
334, 335
Respiratory burst
334
Respiratory syncytial virus infect’n
Interleukin-8
399
mRNA expression
170, 385, 422, 563
Sarcoidosis, analysis in
173
Somatic mutations, dietary effects 322
Transcription factors
266, 335, 344, 350, 357, 393
Treponema pallidum genes
463
Tumour necrosis factor
393
Rodent blood
2-Aminofluorene metabolism
021
Sheep blood
Scapie infection
429
Platelets
Human blood
PRP viscosity adjustment
297
Polymorphonuclear cells (granulocytes)
Canine blood
Ischemia-reperfusion
Na+/H+ exchanger
401
204
Human blood
ß-N-Acetylhexosaminidase
α1-Acid glycoprotein
Activation/adhesion
Adhesion molecules
Calcium levels
cAMP levels
β Catenin redistribution
Chloride efflux
CD11a/b
CD47
Chemotaxis, relation to
117
572
96, 111, 171, 217, 243, 259, 296, 338, 360, 431, 447, 558
080, 435, 446, 469, 557,
549
400, 459
374
105, 164, 171, 277, 464
499
296
Coagulation factor V
Collagen/collagenase
Cytokines
468
028, 042, 057, 359, 599
027, 062, 085, 111, 135, 200, 217, 346, 415, 423, 431, 451, 456, 496, 536,
540, 542, 543, 565
Defensin release
565
Elastase
288, 373, 432, 437, 451, 468, 603
Endothelin-1
145
Ephrin B
534
Fas ligand
207, 208, 284, 537
Fcγ receptor
064, 070, 191, 328
Fibronectin
236, 248
Formyl-peptide receptors
041, 087, 253, 279, 397
Glucosamine, effect
282
GM-CSF
536, 581
Growth factors
256, 464, 480, 551
Heat-shock proteins
321, 508, 529
Helicobacter pylori
086, 458
Herpetic stromal keratitis
536
ß Integrins
215, 248, 338, 376, 423, 481, 579
Ketamine effect
192
Myeloid cell model
428
Myeloperoxidase
068, 069, 450, 503, 505
Nucleosome endocytosis
523
Perflubron
199
Phospholipids
560, 570
Platelet related factors
438, 445, 481, 541, 570
Post-trauma
055, 522
Proteinases
288, 373, 390, 413, 432, 437, 445, 450, 451, 527, 539, 549, 562, 564, 570,
603
Protein kinases
259, 376, 426
Protein nitration
408
Rheumatoid arthritis
056, 605
Selectins
333, 418, 426, 445, 481, 560
Superoxide
195
Thrombocytopenia
131
Thrombin reactions
139, 259, 564
Thrombomodulin
217, 564
Thrombospondin
468
Toll-like receptor
250, 372, 508, 525, 578
Tumour necrosis factor
036, 259, 316, 338, 376, 415, 423, 431, 435, 451, 464, 475, 562, 581
Uridine/uridine derivatives
409
Adenylosuccinate lyase
276
Adhesion, see “Activation/adhesion”
Agammaglobulinemia
063
Aggregation
L-Selectin
038
Alagille syndrome
559
Angina patients
573
Antibody reactions
Anti-neutrophil antibodies
472, 495
ANCA
031, 366, 421, 483, 562, 592
ANCA-associated vasculitis
562
Aplastic anaemia
122
Apoptosis
138, 147, 207, 220, 325, 343, 345, 347, 352, 375, 380, 395, 420, 427, 443,
449, 454, 476, 519, 521, 544, 555, 569, 581, 596, 598
Arachidonic acid metabolites
108, 233, 251, 260, 272, 353, 407, 477, 491, 570, 580
Asialoglycoprotein receptor
262
Aspergillus, see “Fungi, activity against”
Atherosclerosis
061, 065
Bacterial interactions
Anaphylatoxins
Antimicrobial peptides
Bacterial antigens
Bacterial killing
Cytoskeleton interactions
Cytotoxicity
Ferritin mRNA
Fimbriae
Herpes virus entry mediator
Melioidosis
M protein
Oxidation
Pancreatitis
Periodontitis
Peritonitis
Phagocytic process
Phospholipids
PMN pre-activation
Surface interactions
Benzodiazepine receptors
Bone infection detection
Calcium fluxes/modulation
Calreticulin
Carcinoma cells
Adhesion
Cytotoxicity to
G-CSF primed PMNs
Isolation of
Migration
Cardio-thoracic patients/surgery
Caspase-3
Apoptosis
Phagocytosis
α-Tocopherol, effect of
C3a receptor expression
CD11b expression/function
CD16 expression/function
CD18 expression/function
CD31
Functional analysis
CD43
CDCP1 expression
Ceramides
Ceruloplasmin
Chemiluminescence
Chemotaxis
Actin complex, effect of
Adhesion effects
Antimicrobial peptides
Antitrypsin effect
Arachidonic acid metabolites
Calcium effects
Cannabinoids
Cerebrospinal fluid, effect of
Chemoattractant protein 1
Coronin
Cytokines
387
154, 434, 440, 441, 493, 507, 528, 565, 578, 597
511
343, 379, 435, 511, 540, 547
479
271, 368, 378, 443, 449, 454, 471
442
134, 172, 395
478, 525
542, 543, 587, 601
151, 388, 389, 471, 484
377
348
447, 516, 528, 566
398, 456
118, 166, 206, 251, 289, 324, 355, 379, 389, 425, 470, 484, 540, 585, 594,
595
193
067
016, 051, 150, 299, 310, 330, 367, 368, 379, 383, 388, 425, 440, 447, 455,
458, 470, 538, 594
018, 019
223
078, 080, 191, 225, 255, 265, 295, 304, 336, 363, 382, 565, 572
097, 110
023, 270, 311
039, 396
039, 132, 444
047, 077, 126
009
152, 182, 183, 314, 423, 459
569
544
569
120
014, 024
133, 176, 402
014, 024, 260
002
198
510
242, 285
083
019, 032, 408
008, 127, 384, 490
296
434
502
491
419, 446
583
349
005, 084
546
020, 065, 071, 128, 179, 298, 336, 370, 540, 577
Endothelin-1
Estrogen effects
Fas ligand
Fibronectin
G-protein signaling
Glucosamine, effect
Glucose effect
Granule secretion
GM-CSF
ß Integrins
Lipopolysaccharide
Macrophage deactivators
Membrane polarization
Myeloid cell model
fMet-Leu-Phe
Na+/H+ exchange
Phytocannabinoids
Rac activation
Sympathetic nervous system
Complement
Membrane cofactor protein
Receptor expression
Coronary artery disease
Cytomegalovirus
Cytoskeleton
Calcium, effect on
Migration, effect on
Cytotoxicity
Dendritic cells
Activation
Properties acquired by PMNs
Tumour cell hybrids
Diabetic nephropathy
Differentiation
DNA
CpG DNA responses
Genetic heterogeneity
Eosinophil assays
Ethanol effects
Exercise effects
Familial Mediterranean fever
Fanconi anaemia
Fcγ receptors
Expression in cancer patients
Modulation
Respiratory burst, in
Signalling pathways
Fungi, activity against
GABA receptors
Gene expression
Glucosamine
PMN functions, effect on
Glucose transport
Granule secretion
Ca2+ effects
cAMP phosphodiesterase
Degranulation
Glucosmine, effect of
Glutaminase
Microfilaments
128
161
537
066
146
282
180
127
129, 239, 245, 302, 386, 444, 553
407
020, 502, 524
486
261, 318, 433, 497
428
180, 197, 200, 330, 352, 384, 407, 419, 479, 490, 530
582
583
290, 384
007
001
015
577
033
363
261
157, 176, 255, 368, 411, 471, 485, 588
141, 160
245, 278, 313, 482, 508
231
181
245, 292, 405, 439
125, 201, 226, 247, 258, 281, 467, 595, 604
496
512
326
078, 079, 123
246
214
526
132
004, 347
174
191
403, 452, 571, 575, 586, 600
488
568
282
116, 242
304, 435
315
316, 396
282
370
127
Microtubules
127
Phagosome fusion
484
Proteinase 3
163
Hematopoietic cells
G-CSF
111, 341, 342, 474, 386
Hepatitis
194
Heptachlor effects
467
HIV-1
022, 179
Hyper-IgM syndrome
144
Immune reactions
046, 049, 076, 088, 090, 095, 271, 392, 460, 482, 521
MHC-class II antigens
222, 245, 313, 439, 482, 592
Inflammatory processes, see also “Activation/adhesion”
Anaphylatoxins
364
Anti-inflammatory agents
035, 267, 268, 365, 391, 486, 580
Calreticulin
097, 110
Cathepsins
312, 450
Cytokines
103
Estrogen effects
161
Fibronectin
236
Macrophages
025, 598
Oxidation
210, 211, 230
Phospholipid effects
103, 136
Pituitary adenylate cyclase
-activating protein
382
Pregnancy, effect of
041, 211, 483
Rheumatoid arthritis
41, 50, 56, 155, 211, 249, 282
Ropivacaine effects
108
Thrombomodulin
085
TREM-1
372, 492, 556
Kawasaki disease
053
Ischemic lesions
089, 351, 890
Lactoferrin
216
Lipid rafts
557, 585
Lipopolysaccharide response (see also “Chemotaxis”)
CD11b function
024
CD14
011, 347
CD18
024
Cytokines
135, 252, 275, 492
Neutrophil function
024, 273, 275, 415, 482, 524
Respiratory burst
087, 123, 143
Lipoprotein oxidation
061, 091
Leukotrienes, see “Arachidonic acid metabolites”
Lung disorders
182, 195, 540
Metalloproteinases
059, 115, 156 194, 359, 455
Methodology
043
Migration
Adhesion molecules
111, 243, 338, 360, 447, 558
Cannabinoid receptor
497, 518
CD18
260, 473
CD43
198
Cystic fibrosis, effect of
473
Cytokines
111, 200, 203, 209, 228, 260, 273, 339
Cytoskeleton
261, 394
Formyl-tripeptides
228, 253, 497, 530
Fucosyltransferases
287
GM-CSF
111, 332
Growth factors
551
ß Integrins
197, 204, 360, 418
Laminin receptor
332
Leukotriene B4 receptor
477
LFA-1
Macrophage deactivators
Metalloproteinases
Oxododecanoyl-L-homoserine
lactone
Permeability changes
Surface effects
Toll-like receptor
VEGF
Tumour necrosis factor
Myeloproliferative diseases
Neutrophil progenitor cells
Nitric oxide
Nuclei
188
Re and 99mTc labeling
Osteomyelitis
Oxidation effects
Myeloperoxidase/H2O2
NADPH oxidase
Oxygen free radicals
Airborne particles
Arachidonic acid metab.
Angiotensin II
Bacterial killing
Cerebral infarction
Cigarette smoke
Colchicine
Coronary artery disease
Dietary effects
Endurance training
Ethanol
Eviprostat®
Flavonoids
Formyl peptides
Gatifloxacin
Heparin
Hydroxylamine
IgG
Ion fluxes
Irsogladine
Ischemia-reperfusion
Lung injury
Lysosome permeabilization
Measurement
Microtubules
Mitochondria
Osteomyelitis, in
Phospho/sphingolipids
Plasminogen activator
Platelets
Post-operative adhesions
Preeclampsia
Propofol
Protein kinases
Pyrazole derivatives
Seminal cells
Sympathomimetics
Troglitazone
Tumor necrosis factor
Ulcerative colitis
500
486
156
515
279, 412
134, 190, 318
339
228
243, 433
133, 221, 237, 301, 548, 595
341, 342
138, 185, 210, 249, 274, 324, 346, 362, 467, 486, 607
099, 101, 168
405
010, 030, 068, 069, 206, 246, 274, 450
17, 174, 230, 290, 377, 384, 395, 442, 461, 501, 504, 509, 519, 545, 565
100
272
1
334
377, 420
410
461
605
577
264, 294, 335, 352, 417, 448, 607
246
123
550
137
055, 056, 482, 486, 490
305
185
274
210
519, 565
406
351
182, 195
555
453, 506
605
545
405
136, 193, 285, 509
107, 466
356
522
416
408
017, 104, 501, 504, 545
547
102
082
213
036
105, 108, 112, 171, 308
Vicinyl dithiols
037
Wheat-germ agglutinin
533
Superoxide dismutase
029, 040, 055, 100, 182, 246, 274, 591
Oxaliplatin
604
Peptidylarginine deiminase
257
Peroxisome proliferators
170, 267, 365, 520
Phagocytosis, see also “Activation/adhesion”
Antibiotics, effect of
485
Apoptotic PMNs, of
596, 598
Arachidonic acid metabolites 251
Bacteria, of
067, 118, 166, 206, 251, 254, 289, 324, 355, 379, 388, 389, 484, 540
Beads, of
196, 479
Caspase-3
544
Coiling phagocytosis
118
Complement system
146, 206
Coronin
546
Cytoskeleton
394, 531
Exopolysaccharide, effect of
470
Gatifloxacin effects
305
HL60ρ0 cells, compared with 457
Leukotrienes
251
Lipid rafts
585
Opsonized particles
006, 137, 148, 150, 151, 166, 196, 251, 282, 377, 383, 384, 405, 425, 498,
511
Oxidases
435, 509
Protein phosphorylation
148
Seasonal allergic rhinitis, in
460
Septins
893
Sperm, of
006
Yeast, of
070
Zinc, effect of
485
Pharmacokinetics
052, 113, 165, 184, 186, 241, 258, 263, 465, 535, 604
Phospholipids
240
Lysophosphatidic acid
446
Phosphatidylethanol
227
Plamsminogen activator
219
Platelet activation
014, 056, 079, 089, 225, 356
Prostaglandins, see “Arachidonic acid metabolites”
Proteinase expression
045, 155, 163, 286, 320, 539
Proteins
p53
513
Phosphorylation
017, 104, 148, 235, 259, 376, 426, 501, 504
Protoporphyria
125
Protozoa, reactions to
229
Pyelonephritis
203, 576
Renal disease
480
Respiratory burst
026, 036, 037, 041, 042, 044, 075, 086, 087, 112, 174, 230, 277, 308, 316,
334, 352, 353, 354, 355, 382, 386, 446, 457, 469, 490, 540, 557, 607
Respiratory syncytial virus infect’n
Adhesion factors
399, 431
mRNA
081, 098, 124, 183, 232, 385, 422, 456, 468, 542, 543, 559, 563
Rosiglitazone
391, 448
Secretory component
320
Sialic acid
Sialyltransferase
142
Siglec proteins
354, 538, 572
Smoking, effect of
DNA adducts
149, 247, 281, 322
FMet-Leu-Phe receptors
337
NADH oxidases
461
Phagocytois
544
Sperm binding
003, 006, 130
Steroids, effect of
346
Telomerase/telomere
122, 280, 306, 361, 573
Thrombin responses
012
Tissue factor, monocyte-derived 584
Transcription factors
060, 181, 224, 268, 320, 334, 335, 351, 417, 571
Trans-differentiation, see “Differentiation”
Treponema pallidum genes
463
Troglitazone
213, 267, 268, 365
Tumour necrosis factor
011, 013, 020, 029, 079, 087, 123, 179, 273, 277, 291, 300, 354, 358, 380,
390
Virus infection of
034, 121, 159, 487, 498
Wegener's granulomatosis
278, 286, 361, 390, 421
Yeast, see “Fungi, activity against”
Human oral
Apoptosis
Methodology
325
074
Human peritoneal fluid
Peritonitis
398
Porcine blood
Salmonellosis
303
Rabbit blood
Bacterial interactions
Calcium entry
489
072
Rodent blood
Activation
Bacterial infection
Chemotaxis
Copper deficiency
Inflammatory responses
β2 Integrin adhesion
Lipopolysaccharide effects
Nitric oxide
Phagocytosis
Virus infection
106
329
561
309, 404, 436
050
608
153
106, 462
007
048
Rodent pleural exudates
Acute inflammatory effects
323, 331
Sheep blood
Scapie infection
429